TBPH
Price
$11.26
Change
+$0.49 (+4.55%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
562.52M
66 days until earnings call
VERA
Price
$22.75
Change
-$7.88 (-25.73%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
1.45B
62 days until earnings call
Interact to see
Advertisement

TBPH vs VERA

Header iconTBPH vs VERA Comparison
Open Charts TBPH vs VERABanner chart's image
Theravance Biopharma
Price$11.26
Change+$0.49 (+4.55%)
Volume$9.99K
Capitalization562.52M
Vera Therapeutics
Price$22.75
Change-$7.88 (-25.73%)
Volume$243.99K
Capitalization1.45B
TBPH vs VERA Comparison Chart
Loading...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TBPH vs. VERA commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TBPH is a StrongBuy and VERA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (TBPH: $10.78 vs. VERA: $30.63)
Brand notoriety: TBPH and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TBPH: 88% vs. VERA: 217%
Market capitalization -- TBPH: $562.52M vs. VERA: $1.45B
TBPH [@Biotechnology] is valued at $562.52M. VERA’s [@Biotechnology] market capitalization is $1.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TBPH’s FA Score shows that 0 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • TBPH’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, both TBPH and VERA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TBPH’s TA Score shows that 6 TA indicator(s) are bullish while VERA’s TA Score has 5 bullish TA indicator(s).

  • TBPH’s TA Score: 6 bullish, 4 bearish.
  • VERA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TBPH is a better buy in the short-term than VERA.

Price Growth

TBPH (@Biotechnology) experienced а +15.91% price change this week, while VERA (@Biotechnology) price change was +53.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.92%. For the same industry, the average monthly price growth was +17.56%, and the average quarterly price growth was +3.51%.

Reported Earning Dates

TBPH is expected to report earnings on Aug 11, 2025.

VERA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+11.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.45B) has a higher market cap than TBPH($563M). TBPH YTD gains are higher at: 14.559 vs. VERA (-27.572). TBPH has higher annual earnings (EBITDA): -38.45M vs. VERA (-167.77M). VERA has more cash in the bank: 590M vs. TBPH (88.4M). TBPH has less debt than VERA: TBPH (49.8M) vs VERA (54.5M). TBPH has higher revenues than VERA: TBPH (64.4M) vs VERA (0).
TBPHVERATBPH / VERA
Capitalization563M1.45B39%
EBITDA-38.45M-167.77M23%
Gain YTD14.559-27.572-53%
P/E RatioN/AN/A-
Revenue64.4M0-
Total Cash88.4M590M15%
Total Debt49.8M54.5M91%
FUNDAMENTALS RATINGS
TBPH: Fundamental Ratings
TBPH
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TBPHVERA
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
72%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 10 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CHVCX12.920.01
+0.08%
Cullen High Dividend Equity C
MFQTX17.87N/A
N/A
AMG Veritas Global Focus I
SVAIX6.09N/A
N/A
Federated Hermes Strategic Value Div IS
HDIVX17.90N/A
N/A
Janus Henderson Responsible Intl Div I
PMJIX10.44N/A
N/A
PIMCO RAE US Small Instl

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with KYMR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
-2.09%
KYMR - TBPH
40%
Loosely correlated
+7.68%
ELEV - TBPH
39%
Loosely correlated
-0.99%
BPMC - TBPH
38%
Loosely correlated
-0.14%
VERA - TBPH
37%
Loosely correlated
-4.27%
AXON - TBPH
34%
Loosely correlated
+1.08%
More